Loading provider…
Loading provider…
Medical Oncology Physician in Los Angeles, CA
NPI: 1467488015HQ Phone
Get M.D. Barbara's Phone Numberphone_androidMobile
Get M.D. Barbara's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1990 - 2026

American Board of Internal Medicine
Medical Oncology
Renaissance School of Medicine at Stony Brook University
stonybrook.edu
Medical School
Until 1989
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
1992 - 1995
Internship • Internal Medicine
1989 - 1990
Cedars-Sinai Medical Center
Residency • Internal Medicine
1990 - 1992
Authors: Robert Hsu, Geoffrey Oxnard, Joan Schiller
Journal: JTO Clin Res Rep
Publication Date: 2021-05-24
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
Authors: Jeffrey Infante, Heather Wakelee, George Blumenschein, Karen Reckamp, Ticiana Leal, Saiama Waqar
Publication Date: 2017-08-16
Authors: Robert Figlin, Randhir Kaboo, Arie Belldegrun
Journal: J Immunother
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, OTHER: cytology specimen collection procedure
Lead Sponsor: Celgene
Intervention / Treatment: DRUG: Placebo, DRUG: Carboplatin, DRUG: Cisplatin, DRUG: 5-fluorouracil, DRUG: VTX-2337
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, OTHER: Laboratory Biomarker Analysis, DRUG: Gemcitabine Hydrochloride, DRUG: Azacitidine, DRUG: Entinostat, DRUG: Pemetrexed Disodium, DRUG: Irinotecan Hydrochloride